(Q39600335)

13 September 2017

1 reference

title

Phenothiazine-associated lupus anticoagulant and thrombotic disease (English)

1 reference

13 September 2017

1 reference

1 reference

el-Mallakh RS

1

1 reference

13 September 2017

Donaldson JO

series ordinal

2

1 reference

13 September 2017

Kranzler HR

series ordinal

3

1 reference

13 September 2017

Racy A

series ordinal

4

1 reference

13 September 2017

publication date

1 January 1988

1 reference

13 September 2017

1 reference

13 September 2017

volume

29

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

109-113

1 reference

Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

IgM inhibitors of the contact activation phase of coagulation in chlorpromazine-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Cerebral ischemia in the presence of lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Recurrent ischemic attacks in two young adults with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Neurology and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Possible relationship between lupus inhibitor and recurrent abortion in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Lupus anticoagulant, recurrent abortion, and prostacyclin production by cultured smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Obstetric complications associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

MECHANISM OF ACTION OF THE LUPUS ANTICOAGULANT

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Lupus anticoagulant, thrombosis, and fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

An Intrinsic Coagulation Pathway Inhibitor in a 3-year-old Child

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Acquired inhibitors of coagulation in nonhemophiliac children

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Chlorpromazine-induced systemic lupus erythematosus: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2888%2972430-5

7 January 2021

10.1016/S0033-3182(88)72430-5

Identifiers

DOI

0 references

1 reference